Delirium treatment at the geriatric ward (DELTa G)Treatment of delirium: rivastigmine or haloperidol as primary treatment for delirium in delirious patients on a geriatric ward.A randomized placebo-controlled study.
Recruiting
- Conditions
- radndomized placebo-controlled study on a geriatric ward.
- Registration Number
- NL-OMON29295
- Lead Sponsor
- trial medication is sponsored by Novartis
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients on a geriatric ward and delirium.
Exclusion Criteria
1. Already use of rivastigmine/donepezil or galantamine;
2. Parkinson(ism).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength of delirium.
- Secondary Outcome Measures
Name Time Method 1. Length of stay in hospital;<br /><br>2. Severity of delirium;<br /><br>3. Need of escape medication;<br /><br>4. Functional status, 3, 6 and 13 weeks after delirium;<br /><br>5. Cognition.